Historical record - last NADAC publication: 4/4/2013
Product Information
TEMODAR 140 MG CAPSULE is a brand product labeled by Merck Sharp & Dohme LLC, priced at $306.9869 per EA under NDC 00085142504. Its NADAC has been published 17 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Temozolomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
140 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00085142504
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/4/2013
Active Ingredients
TEMOZOLOMIDEApproval Type
New Drug (NDA)
FDA Application
NDA021029On Market Since
8/11/1999
Pharmacological Classes
Price Statistics
The NADAC for TEMODAR 140 MG CAPSULE has been published 17 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $306.9869 per EA |
|---|---|
| All-time high | $306.9869 (Mar 19, 2014) |
| All-time low | $306.9869 (Nov 28, 2013) |
| Median price | $306.9869 |
| Average price | $306.9869 |
| Largest weekly change | 0.0% (Dec 5, 2013) |
| Weeks tracked | 17 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMODAR 140 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMODAR 140 MG CAPSULE, manufactured by Merck Sharp & Dohme LLC, is $306.9869 per EA (NDC 00085142504), effective Mar 19, 2014.
How has the price of TEMODAR 140 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMODAR 140 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 17 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TEMODAR 140 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TEMODAR 140 MG CAPSULE has ranged from a low of $306.9869 (Nov 28, 2013) to a high of $306.9869 (Mar 19, 2014), with a median of $306.9869 per EA.
Are there cheaper alternatives to TEMODAR 140 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TEMOZOLOMIDE 140 MG CAPSULE, is $10.7251 per EA — about 97% below TEMODAR 140 MG CAPSULE.
Who manufactures TEMODAR 140 MG CAPSULE?
TEMODAR 140 MG CAPSULE (NDC 00085142504) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification